Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:4_1:p72
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 4 cl 1 (pt 72/191)
Character Range: 10321038–10335829

procedures - Streamlined Authority Code 6666
                                                                                                                                                                                                                               First-line prevention
                                                                                                                                                                                                                               Patient must be aged 2 to 5 years inclusive;
                                                                                                                                                                                                                               The condition must be frequent intermittent; or
                                                                                                                                                                                                                               The condition must be mild persistent; AND
                                                                                                                                                                                                                               The treatment must be the single preventer agent; AND
                                                                                                                                                                                                                               The treatment must be an alternative to sodium cromoglycate.  or
                                                                                                                                                                                                                               The treatment must be an alternative to nedocromil sodium.
C6674               P6674          CN6674           Montelukast                                                                                                                                                                Asthma                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Compliance with Authority Required procedures - Streamlined Authority Code 6674
                                                                                                                                                                                                                               First-line prevention
                                                                                                                                                                                                                               The condition must be frequent intermittent; or
                                                                                                                                                                                                                               The condition must be mild persistent; AND
                                                                                                                                                                                                                               The treatment must be the single preventer agent; AND
                                                                                                                                                                                                                               The treatment must be an alternative to sodium cromoglycate; or
                                                                                                                                                                                                                               The treatment must be an alternative to nedocromil sodium;
                                                                                                                                                                                                                               Patient must be aged 6 to 14 years inclusive.
C6679               P6679          CN6679           Filgrastim                                                                                                                                                                 Assisting bone marrow transplantation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Compliance with Authority Required procedures - Streamlined Authority Code 6679
                                                                                                                                                                                                                               Patient must be receiving marrow-ablative chemotherapy prior to the transplantation.
C6680               P6680          CN6680           Filgrastim                                                                                                                                                                 Severe congenital neutropenia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Compliance with Authority Required procedures - Streamlined Authority Code 6680
                                                                                                                                                                                                                               Patient must have an absolute neutrophil count of less than 100 million cells per litre measured on 3 occasions, with readings at least 2 weeks apart; AND
                                                                                                                                                                                                                               Patient must have had a bone marrow examination that has shown evidence of maturational arrest of the neutrophil lineage.
C6683               P6683          CN6683           Citrulline with carbohydrate                                                                                                                                               Urea cycle disorders
                                                                                                                                                                                                                               The treatment must be for preventing low plasma arginine levels.  or
                                                                                                                                                                                                                               The treatment must be for preventing low citrulline levels.
C6696               P6696          CN6696           Ixekizumab                                                                                                                                                                 Severe chronic plaque psoriasis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Compliance with Authority Required procedures
                                                                                                                                                                                                                               Continuing treatment, Whole body or Continuing treatment, Face, hand, foot - balance of supply
                                                    Risankizumab                                                                                                                                                               Patient must have received insufficient therapy with this drug under the continuing treatment, Whole body restriction to complete 24 weeks treatment; or
                                                                                                                                                                                                                               Patient must have received insufficient therapy with this drug under the continuing treatment, Face, hand, foot restriction to complete 24 weeks treatment; AND
                                                    Secukinumab                                                                                                                                                                The treatment must provide no more than the balance of up to 24 weeks treatment available under the above restrictions; AND
                                                                                                                                                                                                                               The treatment must be as systemic monotherapy (other than methotrexate); AND
                                                    Ustekinumab                                                                                                                                                                Must be treated by a dermatologist.

C6706               P6706          CN6706           Bromocriptine                                                                                                                                                              Pathological hyperprolactinaemia
                                                                                                                                                                                                                               Patient must have had surgery for this condition with incomplete resolution.
C6707               P6707          CN6707           Bromocriptine                                                                                                                                                              Pathological hyperprolactinaemia
                                                                                                                                                                                                                               Patient must be one in whom radiotherapy is not indicated.
C6717               P6717          CN6717           Bromocriptine                                                                                                                                                              Acromegaly

C6718               P6718          CN6718           Bromocriptine                                                                                                                                                              Parkinson disease

C6719               P6719          CN6719           Bromocriptine                                                                                                                                                              Pathological hyperprolactinaemia
                                                                                                                                                                                                                               Patient must have had radiotherapy for this condition with incomplete resolution.
C6752               P6752          CN6752           Trametinib                                                                                                                                                                 Unresectable Stage III or Stage IV malignant melanoma                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Compliance with Authority Required procedures - Streamlined Authority Code 6752
                                                                                                                                                                                                                               Continuing treatment
                                                                                                                                                                                                                               Patient must have previously been